Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Southall, United Kingdom Clinical Trials

A listing of Southall, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers

A Phase 1 study to assess the effect of itraconazole, a strong inhibitor of CYP3A and P-glycoprotein, on the pharmacokinetics (PK) of orvepitant in healthy male volunteers. Subjects will receive two single doses of 20mg orvepitant, once alone and once in combination with repeat doses of itraconazole. All subjects will ...

Phase

5.01 miles

Learn More »

Performance and Evaluation for CT Colonography Screening

CT Colonography is a test which can can detect early cancer accurately, however, unlike colonoscopy (or mammography in breast cancer screening) there is currently no formalised program to help ensure Radiologists interpret CTC accurately. Colonoscopists are highly regulated, must be accredited and have ongoing quality assurance metrics, based on evidence ...

Phase N/A

5.01 miles

Learn More »

Machine Learning in Myeloma Response

Rationale Diffusion-weighted whole body magnetic resonance imaging (WB-MRI) is a technique that depicts myeloma deposits in the bone marrow. WB-MRI covers the entire body during the course of a single scan and can be used to detect sites of disease without using ionising radiation. Although WB-MRI allows for "at a ...

Phase N/A

6.14 miles

Learn More »

Microbial Basis of Systemic Malodor and PATM Conditions

Human odorprints, mostly owing to the microbiome, have proven their value as biomarkers of health and environmental exposures. In recent years, microbial networks responsible for localized malodors such as halitosis or axillary odor have been mapped by using next generation sequencing approaches. Intestinal microbes responsible for psychologically debilitating systemic malodor ...

Phase N/A

6.63 miles

Learn More »

Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial

This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to evaluate safety of immune tolerance induction (ITI) treatment with turoctocog alfa (a recombinant factor VIII) in patients who have developed neutralising antibodies against factor VIII after exposure to subcutaneous ...

Phase

9.56 miles

Learn More »